AlzeCure Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	455	230	102	193	257	225
Market Cap Growth	109.51%	126.34%	-47.41%	-24.88%	14.39%	-34.33%
Enterprise Value	424	173	62	156	220	162
Last Close Price	3.96	2.00	1.09	2.79	3.71	5.12
PB Ratio	40.54	6.98	3.90	8.12	4.25	6.82
P/TBV Ratio	40.60	6.99	3.90	8.13	4.25	6.82
P/FCF Ratio	-	-	-	63.16	-	-
P/OCF Ratio	-	-	-	63.16	-	-
EV/FCF Ratio	-	-	-	50.91	-	-
Debt / Equity Ratio	0.20	0.12	0.19	-	-	-
Net Debt / Equity Ratio	-2.73	-1.41	-1.02	-1.22	-0.42	-1.27
Net Debt / EBITDA Ratio	0.53	1.00	0.76	0.77	0.46	0.54
Net Debt / FCF Ratio	0.74	1.34	0.77	-9.52	0.26	0.59
Quick Ratio	1.30	2.28	3.49	3.72	2.60	3.42
Current Ratio	1.36	2.33	3.55	3.84	2.66	3.49
Return on Equity (ROE)	-433.79%	-161.56%	-141.83%	-88.22%	-120.35%	-108.23%
Return on Assets (ROA)	-113.69%	-61.00%	-63.14%	-46.61%	-60.70%	-59.75%
Return on Capital Employed (ROCE)	-440.80%	-135.20%	-121.20%	-161.30%	-93.50%	-237.00%
Earnings Yield	-13.01%	-20.73%	-34.81%	-19.25%	-21.88%	-34.62%
FCF Yield	-	-15.05%	-33.83%	1.58%	-38.87%	-31.46%
Buyback Yield / Dilution	-28.01%	-30.26%	-24.26%	-30.17%	-26.30%	-